253 related articles for article (PubMed ID: 13680386)
1. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.
Proesmans M; De Boeck K
Eur J Pediatr; 2003 Nov; 162(11):760-3. PubMed ID: 13680386
[TBL] [Abstract][Full Text] [Related]
2. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
[TBL] [Abstract][Full Text] [Related]
4. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
Heijerman HG
Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
[TBL] [Abstract][Full Text] [Related]
7. Effects of a proton-pump inhibitor in cystic fibrosis.
Tran TM; Van den Neucker A; Hendriks JJ; Forget P; Forget PP
Acta Paediatr; 1998 May; 87(5):553-8. PubMed ID: 9641739
[TBL] [Abstract][Full Text] [Related]
8. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis.
Francisco MP; Wagner MH; Sherman JM; Theriaque D; Bowser E; Novak DA
J Pediatr Gastroenterol Nutr; 2002 Jul; 35(1):79-83. PubMed ID: 12142815
[TBL] [Abstract][Full Text] [Related]
9. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
10. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
[TBL] [Abstract][Full Text] [Related]
11. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
[TBL] [Abstract][Full Text] [Related]
12. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
Calvo-Lerma J; Roca M; Boon M; Colombo C; de Koning B; Fornés-Ferrer V; Masip E; Garriga M; Bulfamante A; Asensio-Grau A; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
Pediatr Res; 2021 Jan; 89(1):205-210. PubMed ID: 32247283
[TBL] [Abstract][Full Text] [Related]
13. Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.
Cohen JR; Schall JI; Ittenbach RF; Zemel BS; Stallings VA
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):438-44. PubMed ID: 15795591
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis.
Woestenenk JW; van der Ent CK; Houwen RH
J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):355-60. PubMed ID: 25782658
[TBL] [Abstract][Full Text] [Related]
15. Effects of pancreatic enzyme preparations on erythrocyte glutathione peroxidase activities and plasma selenium concentrations in cystic fibrosis.
Winklhofer-Roob BM; Tiran B; Tuchschmid PE; van't Hof MA; Shmerling DH
Free Radic Biol Med; 1998 Jul; 25(2):242-9. PubMed ID: 9667502
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of faecal lipase test and faecal elastase-1 test in the assessment of exocrine pancreatic function in cystic fibrosis].
Walkowiak J; Herzig KH; Strzykala K; Lisowska A; Przyslawski J; Grzymislawski M; Krawczynski M
Med Wieku Rozwoj; 2003; 7(2):149-55. PubMed ID: 12878785
[TBL] [Abstract][Full Text] [Related]
17. Unresponsive or non-compliant steatorrhea in cystic fibrosis?
Lisowska A; Kaminska B; Grzymislawski M; Herzig KH; Walkowiak J
J Cyst Fibros; 2006 Dec; 5(4):253-5. PubMed ID: 16765107
[TBL] [Abstract][Full Text] [Related]
18. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.
Durie PR; Bell L; Linton W; Corey ML; Forstner GG
Gut; 1980 Sep; 21(9):778-86. PubMed ID: 7429342
[TBL] [Abstract][Full Text] [Related]
19. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
Konstan MW; Stern RC; Trout JR; Sherman JM; Eigen H; Wagener JS; Duggan C; Wohl ME; Colin P
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1365-71. PubMed ID: 15606399
[TBL] [Abstract][Full Text] [Related]
20. Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis.
Walkowiak J; Lisowska A; Przyslawski J; Grzymislawski M; Krawczynski M; Herzig KH
Acta Paediatr; 2004 Aug; 93(8):1042-5. PubMed ID: 15456193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
